Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy by Betty Chamoun, Pablo Sánchez-Sancho, Irina B. Torres, Alejandra Gabaldon, Manel Perelló, Joana Sellarés, Francesc Moreso, Daniel Serón

Get full text

Tocilizumab en el tratamiento del rechazo humoral crónico activo resistente a terapia estándar by Betty Chamoun, Pablo Sánchez-Sancho, Irina B. Torres, Alejandra Gabaldon, Manel Perelló, Joana Sellarés, Francesc Moreso, Daniel Serón

Get full text

Clinical outcomes of the inclusion of the therapeutic drug monitoring report in the electronic clinical record by Marina Sáez Belló, Ana Moya Gil, Mª Ángeles López Montenegro Soria, Pablo Sánchez Sancho, Pau Frias Ruiz, Mónica Climente Martí

Get full text